Literature DB >> 7769145

Laminin expression in testicular tumours of the dog.

C Benazzi1, G Sarli, R Preziosi, P S Marcato.   

Abstract

The expression of laminin was studied to determine the distribution pattern of basement membranes (BMs) in normal testes and in a series of 40 canine testicular tumours (seminomas, Leydig and Sertoli cell tumours). BM was always present around seminiferous tubules and blood vessels in normal testes and in seminomas and Sertoli cell tumours of the intratubular type without invasion. BM changes (fragmentation or loss, or both) were usually found in invasive neoplasms which retained their tubular structure; disruption or absence was observed in tumours, with a diffuse pattern. The BM was never expressed in Leydig cell tumours, except around vessels, irrespective of their histological growth pattern (cystic-vascular, pseudoadenomatous, diffuse). An attempt was made to relate the degree of BM modification to proliferative monoclonal antibodies and mitotic index. In parallel with the progressive loss of BM an increase in proliferative activity occurred, indicating that BM changes are additional useful prognostic indicators in testicular tumours of the dog.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769145     DOI: 10.1016/s0021-9975(05)80057-x

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  2 in total

1.  Comparative expression of laminin and smooth muscle actin in the testis and epididymis of poultry and rabbit.

Authors:  Ahmed Abd-Elmaksoud
Journal:  J Mol Histol       Date:  2010-02-16       Impact factor: 2.611

2.  Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy.

Authors:  J Javanbakht; B Pedram; M R Taheriyan; F Khadivar; S H Hosseini; F S Abdi; E Hosseini; M Moloudizargari; S H Aghajanshakeri; S Javaherypour; R Shafiee; R Emrani Bidi
Journal:  Tumour Biol       Date:  2014-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.